Loading institutional data...
Loading institutional data...
Held by 335 of 5,944 reporting institutions (95th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $16.24 today, the market must believe free cash flow compounds 20.9%/yr for a decade (off $72M normalized FCF).
The market's 20.9% is more conservative than its 7-yr track record.
2-stage DCF · 0.23B shares · net debt $32M
mean 372.1% · volatility σ 562% · implied rate exceeded in 2/3 yrs
Central path = implied 20.9%/yr growth; shaded band = ±1σ (562%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2021 | FY2020 | FY2020 | FY2019 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $925.4M 100.0% | $860.8M 100.0% | $800.9M 100.0% | $717.8M 100.0% | — | $611.6M 100.0% | — | $478.2M 100.0% | — | $440.1M 100.0% |
| Cost of Revenue | $486.8M 52.6% | $461.1M 53.6% | $444.5M 55.5% | $407.7M 56.8% | — | $359.8M 58.8% | — | $281.2M 58.8% | — | $251.9M 57.2% |
| Gross Profit | $438.6M 47.4% | $399.7M 46.4% | $356.4M 44.5% | $310.1M 43.2% | — | $251.8M 41.2% | — | $197.0M 41.2% | — | $188.2M 42.8% |
| Research & Development | $38.9M 4.2% | $35.0M 4.1% | $31.7M 4.0% | $30.3M 4.2% | — | $29.4M 4.8% | — | $15.9M 3.3% | — | $14.0M 3.2% |
| Selling, General & Admin | $348.2M 37.6% | $341.1M 39.6% | $340.1M 42.5% | $362.3M 50.5% | — | $211.2M 34.5% | $2.4M | $158.1M 33.1% | $341 | $145.4M 33.0% |
| Total Operating Expenses | $387.1M 41.8% | $374.9M 43.6% | $378.3M 47.2% | $607.9M 84.7% | — | $240.6M 39.3% | — | $174.0M 36.4% | — | $159.4M 36.2% |
| Operating Income | $51.5M 5.6% | $24.8M 2.9% | -$21.9M -2.7% | -$297.8M -41.5% | — | $11.2M 1.8% | — | $23.0M 4.8% | — | $28.8M 6.5% |
| Interest Expense | $42.2M 4.6% | $57.9M 6.7% | $61.9M 7.7% | — | — | — | — | — | — | — |
| Interest & Investment Income | $12.1M 1.3% | $6.6M 0.8% | $4.8M 0.6% | $600K 0.1% | — | $200K 0.0% | — | — | — | — |
| Other Income (Expense), net | -$300K -0.0% | $100K 0.0% | $800K 0.1% | $400K 0.1% | — | $1.1M 0.2% | — | $1.0M 0.2% | — | -$1.9M -0.4% |
| Pretax Income | $32.7M 3.5% | -$33.9M -3.9% | -$105.3M -13.1% | -$306.6M -42.7% | — | -$164.3M -26.9% | -$45.5M | -$124.6M -26.1% | -$341 | -$126.2M -28.7% |
| Income Tax Expense | $2.9M 0.3% | $2.7M 0.3% | -$6.6M -0.8% | -$18.2M -2.5% | — | -$5.9M -1.0% | -$266K | -$5.5M -1.2% | $0 | -$4.2M -1.0% |
| Net Income | $28.8M 3.1% | -$36.1M -4.2% | -$96.9M -12.1% | -$276.9M -38.6% | -$158.4M | -$158.3M -25.9% | -$45.3M | -$119.1M -24.9% | -$341 | -$122.0M -27.7% |
| Per Share | ||||||||||
| EPS (Basic) | $0.13 | $-0.18 | $-0.49 | $-1.53 | — | $-24.18 | — | $-18.45 | — | $-19.36 |
| EPS (Diluted) | $0.11 | $-0.18 | $-0.49 | $-1.53 | — | $-24.18 | — | $-18.45 | — | $-19.36 |
| Weighted Avg Shares (Basic) | 230.0M | 205.0M | 196.4M | 181.1M | — | 6.5M | — | 6.5M | — | 6.3M |
| Weighted Avg Shares (Diluted) | 261.2M | 205.0M | 196.4M | 181.1M | — | 6.5M | — | 6.5M | — | 6.3M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $50M buybacks = $50M returned on $107M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 1%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $412M covers the $1M due within a year 343.6× over. Scheduled principal only (excludes interest & revolver draws). As of 2024-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~9.5% on $445M of debt.
Cash of $412M fully covers short-term debt of $2M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 7-yr range · 57th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 7-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 14.3× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2020 | FY2020 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 58.8 | — | 58.8 | — | 56.8 | 55.5 | 53.6 | 52.6 |
| Gross Profit | 41.2 | — | 41.2 | — | 43.2 | 44.5 | 46.4 | 47.4 |
| R&D | 3.3 | — | 4.8 | — | 4.2 | 4.0 | 4.1 | 4.2 |
| SG&A | 33.1 | — | 34.5 | — | 50.5 | 42.5 | 39.6 | 37.6 |
| Operating Income | 4.8 | — | 1.8 | — | -41.5 | -2.7 | 2.9 | 5.6 |
| Income Tax | -1.2 | — | -1.0 | — | -2.5 | -0.8 | 0.3 | 0.3 |
| Net Income | -24.9 | — | -25.9 | — | -38.6 | -12.1 | -4.2 | 3.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MIR: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $29.49T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $371.6B | 42.5× | 29.7× | 5.5× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $328.8B | 38.5× | — | 7.2× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $259.8B | 39.0× | 18.5× | 2.9× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $199.4B | 79.4× | 40.2× | 2.2× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $185.4B | 37.1× | — | 4.1× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $177.4B | 47.9× | 31.6× | 5.5× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $167.6B | 23.6× | 16.1× | 6.8× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $158.8B | 39.2× | — | 5.8× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $131.2B | 28.1× | 16.1× | 3.5× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $123.2B | 25.0× | 16.1× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $118.7B | 34.1× | 26.8× | 6.0× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $108.3B | 24.9× | — | 4.9× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $96.2B | 23.0× | 16.9× | 1.8× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $94.4B | 32.6× | 23.3× | 4.4× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| VRT | $92.4B | 70.8× | 43.8× | 9.0× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| PWR | $92.2B | 90.7× | 45.8× | 3.2× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| JCI | $91.9B | 28.0× | — | 3.9× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| HWM | $90.7B | 60.9× | 39.9× | 11.0× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $89.1B | 31.1× | 14.4× | 6.3× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| MMM | $87.3B | 27.4× | 16.8× | 3.5× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| WM | $86.0B | 31.8× | 12.1× | 3.4× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $85.0B | 15.3× | 9.5× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| EMR | $83.0B | 36.5× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $79.8B | 45.0× | 28.7× | 7.7× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| MIR | $3.7B | 147.6× | 19.9× | 4.0× | 7.5% | 47.4% | 3.1% | 1.5% | 1.2% | 2.3× | 335 |
Peers = companies sharing MIR's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.